Assay
Mobile phase
Mix 50 mL of glacial acetic acid and 930 mL of water, and adjust with 1 N sodium hydroxide to a pH of 3.40. Mix about 4 volumes of this solution with 1 volume of acetonitrile, such that the retention time of prilocaine is about 4 to 6 minutes. Filter through a membrane filter (1 µm or finer porosity), and degas. Make adjustments if necessary (see
System Suitability under
Chromatography 621).
Standard preparation
Dissolve an accurately weighed quantity of
USP Prilocaine Hydrochloride RS quantitatively in
Mobile phase to obtain a solution having a known concentration of about 4 mg per mL.
Assay preparation
Transfer an accurately measured volume of Injection, equivalent to about 200 mg of prilocaine hydrochloride, to a 50-mL volumetric flask, dilute with Mobile phase to volume, and mix.
Resolution preparation
Prepare a solution of procainamide hydrochloride in Mobile phase containing about 900 µg per mL. Mix 2 mL of this solution and 20 mL of Standard preparation.
Chromatographic system
(see
Chromatography 621)The liquid chromatograph is equipped with a 254-nm detector and a 3.9-mm × 30-cm column that contains packing L1, and is operated at a temperature between 20
and 25
maintained at ±1.0
of the selected temperature. The flow rate is about 1.5 mL per minute. Chromatograph the
Standard preparation, and record the peak responses as directed for
Procedure: the relative standard deviation for replicate injections is not more than 1.5%. Chromatograph about 10 µL of the
Resolution preparation, and record the peak responses as directed for
Procedure: the resolution,
R, between the prilocaine and procainamide peaks is not less than 2.0.
Procedure
[NOTEUse peak areas where peak responses are indicated.
] Separately inject equal volumes (about 10 µL) of the
Standard preparation and the
Assay preparation into the liquid chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the quantity, in mg, of C
13H
20N
2O·HCl in each mL of the Injection taken by the formula:
(50)(C / V)(rU / rS),
in which
C is the concentration, in mg per mL, of
USP Prilocaine Hydrochloride RS in the
Standard preparation,
V is the volume, in mL, of Injection taken, and
rU and
rS are the peak responses obtained from the
Assay preparation and the
Standard preparation, respectively.